Journal article Published 2024

A phase 1/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma

J. Huang, J.L. Campian, T.A. DeWees, Zdeněk Škrott, Martin Mistrík, T.M. Johanns, G. Ansstas, O. Butt, E. Leuthardt, G.P. Dunn, G.J. Zipfel, J.W. Osbun, Ch. Abraham, S. Badiyan, K. Schwetye,

Show all 19 authors

J.G. Cairncross, J.B. Rubin, A.H. Kim, M.G. Gheda

International Journal of Radiation Oncology, Biology, Physics 120(3), 738-749 (2024)

View on PubMed Cite

2024 Year
38768767 PMID

Cite this publication

HUANG, J., J. CAMPIAN, T. DEWEES, Z. ŠKROTT, M. MISTRÍK, T. JOHANNS, G. ANSSTAS, O. BUTT, E. LEUTHARDT, G. DUNN, G. ZIPFEL, J. OSBUN, C. ABRAHAM, S. BADIYAN, K. SCHWETYE, J. CAIRNCROSS, J. RUBIN, A. KIM, M. GHEDA: A phase 1/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma. International Journal of Radiation Oncology, Biology, Physics. 2024, 120(3), 738-749, ISSN: 0360-3016, PMID: 38768767.

Details

ISSN: 0360-3016

Cite this publication

Details

Authors from IMTM